Original Research

Published on 15 Oct 2024

Integrating clinical and genomic landscape analysis of perineural invasion identify ACTA1 as an oncogene for oral squamous cell carcinoma

in Cancer Cell Biology

Sheng Chen
Tongchao Zhao
Yuxian Song
Xiaofeng Huang
Yanhong Ni
Liang Ding
Yong Fu
Qingang Hu
Yi Wang

Frontiers in Cell and Developmental Biology

doi 10.3389/fcell.2024.1458879

539 views

Original Research

Published on 14 Oct 2024

PD-1 inhibitor sintilimab treated patients with metastatic triple-negative breast cancer

in Cancer Cell Biology

Yan Jia
Jie Zhang
Yehui Shi
Guolei Dong
Xiaojing Guo
Zhongsheng Tong

Frontiers in Cell and Developmental Biology

doi 10.3389/fcell.2024.1430310

926 views

Review

Published on 08 Oct 2024

Emerging roles of cancer-associated histone mutations in genomic instabilities

in Cancer Cell Biology

Priyanka Yadav
Ronit Jain
Rajesh Kumar Yadav

Frontiers in Cell and Developmental Biology

doi 10.3389/fcell.2024.1455572

1,281 views

Editorial

Published on 07 Oct 2024

Editorial: Understanding the mesenchymal to epithelial transition: a much needed angle for epithelial mesenchymal plasticity

in Cancer Cell Biology

Hani Alotaibi
Ralph Meuwissen
A. Emre Sayan

Frontiers in Cell and Developmental Biology

doi 10.3389/fcell.2024.1497515

396 views

Review

Published on 03 Oct 2024

CAR-macrophage: Breaking new ground in cellular immunotherapy

in Cancer Cell Biology

Ting Huang
Chenqi Bei
Zhenhua Hu
Yuanyuan Li

Frontiers in Cell and Developmental Biology

doi 10.3389/fcell.2024.1464218

1,622 views

Mini Review

Published on 30 Sep 2024

The potential of diallyl trisulfide for cancer prevention and treatment, with mechanism insights

in Cancer Cell Biology

Ling Lu
Zihan Gao
Jiajia Song
Longtao Jin
Zhaofeng Liang

Frontiers in Cell and Developmental Biology

doi 10.3389/fcell.2024.1450836

475 views

Editorial

Published on 27 Sep 2024

Editorial: Lipid alterations in cancer development, resistance and recurrence

in Cancer Cell Biology

F. Pagliari
S. Di Franco
L. Tirinato

Frontiers in Cell and Developmental Biology

doi 10.3389/fcell.2024.1493626

345 views

Mini Review

Published on 27 Sep 2024

Regulation of p53 by the mitotic surveillance/stopwatch pathway: implications in neurodevelopment and cancer

in Cancer Cell Biology

Travis H. Stracker

Frontiers in Cell and Developmental Biology

doi 10.3389/fcell.2024.1451274

680 views

Review

Published on 26 Sep 2024

Dysregulation of lysine acetylation in the pathogenesis of digestive tract cancers and its clinical applications

in Cancer Cell Biology

Penghui Li
Yuan Xue

Frontiers in Cell and Developmental Biology

doi 10.3389/fcell.2024.1447939

800 views

Review

Accepted on 23 Sep 2024

Insights and Therapeutic Advances in Pancreatic Cancer: The Role of Electron Microscopy in Decoding the Tumor Microenvironment

in Cancer Cell Biology

Hong Dai
Xingxuan Chen
Jiawen Yang
Yuying Wang
Rodrigo Azevedo Loiola
Aiping Lyu
Kenneth C.P Cheung

Frontiers in Cell and Developmental Biology

doi 10.3389/fcell.2024.1460544

187 views

Original Research

Published on 20 Sep 2024

YTHDF3 modulates the progression of breast cancer cells by regulating FGF2 through m6A methylation

in Cancer Cell Biology

R. F. Gong
Z. H. Zhang
T. T. Sun
Y. X. Zhao
Wen Fang

Frontiers in Cell and Developmental Biology

doi 10.3389/fcell.2024.1438515

862 views

Mini Review

Published on 20 Sep 2024

Small molecule Mcl-1 inhibitor for triple negative breast cancer therapy

in Cancer Cell Biology

Shengli Dong
Suresh K. Alahari

Frontiers in Cell and Developmental Biology

doi 10.3389/fcell.2024.1408107

776 views

Original Research

Published on 16 Sep 2024

Integrating oxidative-stress biomarkers into a precision oncology risk-stratification model for bladder cancer prognosis and therapy

in Cancer Cell Biology

Jianxu Huang
Dewang Zhou
Weihan Luo
Yujun Liu
Haoxiang Zheng
Yongqiang Wang

Frontiers in Cell and Developmental Biology

doi 10.3389/fcell.2024.1453448

610 views

Mini Review

Published on 13 Sep 2024

Chromosomal instability as an architect of the cancer stemness landscape

in Cancer Cell Biology

Shahnawaz A. Baba
Aran Zakeri
Jay S. Desgrosellier

Frontiers in Cell and Developmental Biology

doi 10.3389/fcell.2024.1450614

721 views

Original Research

Published on 05 Sep 2024

Diagnostic value of multimodal ultrasound for breast cancer and prediction of sentinel lymph node metastases

in Cancer Cell Biology

Hui Li
Lixia Chen
Meikuai Liu
Meng Bao
Quanbo Zhang
Shihao Xu

Frontiers in Cell and Developmental Biology

doi 10.3389/fcell.2024.1431883

706 views

Original Research

Published on 04 Sep 2024

Evaluation of prognostic risk factors of triple-negative breast cancer with 18F-FDG PET/CT parameters, clinical pathological features and biochemical indicators

in Cancer Cell Biology

Lei Zhu
Xin Yang
Jiying Zhang
Shuling Wang
Yulong Wang
Xing Wan
Xiang Zhu
Xiuyu Song
Zhongsheng Tong
Meng Yang

Frontiers in Cell and Developmental Biology

doi 10.3389/fcell.2024.1421981

999 views

Navigation group

Articles

Integrating clinical and genomic landscape analysis of perineural invasion identify ACTA1 as an oncogene for oral squamous cell carcinoma

PD-1 inhibitor sintilimab treated patients with metastatic triple-negative breast cancer

Emerging roles of cancer-associated histone mutations in genomic instabilities

Editorial: Understanding the mesenchymal to epithelial transition: a much needed angle for epithelial mesenchymal plasticity

CAR-macrophage: Breaking new ground in cellular immunotherapy

The potential of diallyl trisulfide for cancer prevention and treatment, with mechanism insights

Editorial: Lipid alterations in cancer development, resistance and recurrence

Regulation of p53 by the mitotic surveillance/stopwatch pathway: implications in neurodevelopment and cancer

Dysregulation of lysine acetylation in the pathogenesis of digestive tract cancers and its clinical applications

Insights and Therapeutic Advances in Pancreatic Cancer: The Role of Electron Microscopy in Decoding the Tumor Microenvironment

YTHDF3 modulates the progression of breast cancer cells by regulating FGF2 through m6A methylation

Small molecule Mcl-1 inhibitor for triple negative breast cancer therapy

Integrating oxidative-stress biomarkers into a precision oncology risk-stratification model for bladder cancer prognosis and therapy

Chromosomal instability as an architect of the cancer stemness landscape

Diagnostic value of multimodal ultrasound for breast cancer and prediction of sentinel lymph node metastases

Evaluation of prognostic risk factors of triple-negative breast cancer with 18F-FDG PET/CT parameters, clinical pathological features and biochemical indicators